NYSE - Nasdaq Real Time Price USD

Baxter International Inc. (BAX)

40.40

+0.93

(+2.36%)

At close: April 22 at 4:00 PM EDT

Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio

Baxter (BAX) unveils its five injectable products, which strengthen its emphasis on unique products and expand the pharmaceutical portfolio of the business in important therapeutic areas.

Zacks 10 days ago

BAX
+2.36%
CAH
-4.95%
LMAT
Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day

Comfort Systems USA and Boeing are part of the Zacks Bull and Bear of the Day article.

Zacks 10 days ago

BA

FIX

BAX
+2.36%
3 Medical Device Stocks With Solid Dividend Yield: CAH & Others

Here we discuss three medical device stocks, Cardinal Health (CAH), Baxter International (BAX) and Fresenius Medical Care (FMS), with a solid five-year dividend growth history.

Zacks 11 days ago

CAH
-4.95%
BAX
+2.36%
FME.DE
Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.

DEERFIELD, Ill., April 11, 2024--Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, announced the continued expansion of its Pharmaceuticals portfolio with five injectable product launches in the U.S.

Business Wire 11 days ago

BAX
+2.36%
Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors

DEERFIELD, Ill., April 10, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information.

Business Wire 12 days ago

BAX
+2.36%
Reasons to Hold Baxter International (BAX) in Your Portfolio

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, raises optimism.

Zacks 12 days ago

BAX
+2.36%
CAH
-4.95%
LMAT
Baxter Is Deeply Undervalued

The company is undergoing a transformation to a focused health care player

GuruFocus.com 12 days ago

BAX
+2.36%
Shareholders in Baxter International (NYSE:BAX) are in the red if they invested three years ago

For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you...

Simply Wall St. 17 days ago

BAX
+2.36%
Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy

Baxter's (BAX) Novum IQ Infusion Platform is likely to help enhance patient safety and efficiency for clinicians following the FDA's clearance.

Zacks 20 days ago

BAX
+2.36%
DVA

CAH
-4.95%
Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

DEERFIELD, Ill., April 01, 2024--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. Adding LVP modality to the Novum IQ Infusion Platform – which includes Baxter’s syringe infusion pump (SYR) with Dose IQ Safety Software, powered by the IQ Enterprise Connectivity Suite – enables clinicians to utiliz

Business Wire 21 days ago

BAX
+2.36%
Baxter to Host Annual Meeting of Stockholders in Virtual Format

DEERFIELD, Ill., March 27, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2024 Annual Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2024 Annual Meeting. Online access to the 2024 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be able to attend the 2024 Annual Meeting in person. The virtual format provides a convenien

Business Wire 26 days ago

BAX
+2.36%
Don't 'run away' from tech, but do broaden out: Strategist

Yahoo Finance Live revisits the calls made at the end of last year to see which hold up and which are in need of repositioning. Laffer Tengler Investments CEO & CIO Nancy Tengler and Great Hill Capital Chairman and Managing Member Thomas Hayes join Yahoo Finance to revisit and update last year's calls. Hayes outlines his market strategy amid a surging market: "We've been publicly bullish nonstop for a year and a half, and we've recently become more cautious. We're up 17 out of the last 21 weeks. No 2% pullback in the last 100 trading days. So, in recent weeks, we put on a 2% hedge: 1% put spreads on the S&P, 1% put spreads on the semiconductor index, and 98% long. So if we're right, those have an expected value of 5x each." Tengler addresses risks on her radar: "We started broadening out the portfolio, really to have the improvement in some of the names that we've seen in healthcare, financials, some of the more cyclical names...But my biggest concern is that the Fed seems to be, I guess, walking away from their data dependence, and I'll put quotes around that, that they've had in the past. And it seems they're determined to cut. We've drawn an analogy to the 90s. We think you can have higher inflation, but not materially higher. So that's my worry, that we get a surge in inflation because the Fed is too easy." For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live. Editor's note: This article was written by Nicholas Jacobino

Yahoo Finance Video 27 days ago

LLY

BA

BAX
+2.36%
Should You Hold Baxter International (BAX)?

Artisan Partners, an investment management company, released its “Artisan Value Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. US Treasury yields saw a significant decline towards the end of 2023, which led to a massive surge in the last two months of the year for US stocks. The fund’s […]

Insider Monkey last month

BAX
+2.36%
Baxter to close Massachusetts site, lay off 59 people

News of the cuts comes 13 months after the company outlined plans to eliminate 3,000 positions.

MedTech Dive last month

BAX
+2.36%
Insider Sell: EVP, Chief HR Officer Jeanne Mason Sells 64,488 Shares of Baxter International ...

Jeanne Mason, Executive Vice President and Chief Human Resources Officer, has sold 64,488 shares of Baxter International Inc (NYSE:BAX) on March 1, 2024, according to a recent SEC Filing.

GuruFocus.com last month

BAX
+2.36%
Baxter considers selling kidney care unit to private equity

The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.

MedTech Dive last month

BAX
+2.36%
Baxter to Present at Raymond James 45th Annual Institutional Investors Conference

DEERFIELD, Ill., February 29, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time.

Business Wire last month

BAX
+2.36%
It Might Not Be A Great Idea To Buy Baxter International Inc. (NYSE:BAX) For Its Next Dividend

Baxter International Inc. ( NYSE:BAX ) is about to trade ex-dividend in the next four days. The ex-dividend date is one...

Simply Wall St. last month

BAX
+2.36%
20 Fastest Growing Biotech Companies in the US

In this article, we will be taking a look at the 20 fastest growing biotech companies in the US. If you are not interested in learning about the landscape of biotech companies, head straight to the 5 Fastest Growing Biotech Companies In The US. The biotechnology sector in the United States is witnessing a surge […]

Insider Monkey last month

JNJ

TAK

LLY
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

Baxter to act as exclusive partner to Spectral for 10 years following PMX approval by U.S. FDATORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, is pleased to announce an extension to its supply and distribution agreement (the “Amended Agreement”) with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (“Baxter”) (NYSE: BAX), or

GlobeNewswire last month

EDTXF

BAX
+2.36%

Performance Overview

Return	BAX	S&P 500
YTD	+5.24%	+5.05%
1-Year	-8.16%	+21.22%
3-Year	-50.98%	+20.06%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Baxter International Inc. (BAX)

Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio

Comfort Systems USA and Boeing have been highlighted as Zacks Bull and Bear of the Day

3 Medical Device Stocks With Solid Dividend Yield: CAH & Others

Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.

Baxter to Host First-Quarter 2024 Financial Results Conference Call for Investors

Reasons to Hold Baxter International (BAX) in Your Portfolio

Baxter Is Deeply Undervalued

Shareholders in Baxter International (NYSE:BAX) are in the red if they invested three years ago

Baxter's (BAX) Latest FDA Approval to Boost Infusion Therapy

Baxter Announces U.S. FDA Clearance of Novum IQ Large Volume Infusion Pump and Dose IQ Safety Software, Advancing Connected and Intelligent Infusion Therapy

Baxter to Host Annual Meeting of Stockholders in Virtual Format

Don't 'run away' from tech, but do broaden out: Strategist

Should You Hold Baxter International (BAX)?

Baxter to close Massachusetts site, lay off 59 people

Insider Sell: EVP, Chief HR Officer Jeanne Mason Sells 64,488 Shares of Baxter International ...

Baxter considers selling kidney care unit to private equity

Baxter to Present at Raymond James 45th Annual Institutional Investors Conference

It Might Not Be A Great Idea To Buy Baxter International Inc. (NYSE:BAX) For Its Next Dividend

20 Fastest Growing Biotech Companies in the US

Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation

Performance Overview